Jump Financial, LLC Vir Biotechnology, Inc. Transaction History

Jump Financial, LLC

  • $4.56 Billion
  • Q3 2024

A detailed history of Jump Financial, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 32,862 shares of VIR stock, worth $242,521. This represents 0.01% of its overall portfolio holdings.

Number of Shares
32,862
Previous 115,683 71.59%
Holding current value
$242,521
Previous $1.03 Million 76.09%
% of portfolio
0.01%
Previous 0.02%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$7.26 - $10.7 $601,280 - $886,184
-82,821 Reduced 71.59%
32,862 $246,000
Q2 2024

Aug 14, 2024
BUY
$7.63 - $12.66 $272,963 - $452,911
35,775 Added 44.77%
115,683 $1.03 Million
Q1 2024

May 13, 2024
BUY
$8.6 - $11.9 $687,208 - $950,905
79,908 New
79,908 $809,000
Q3 2023

Oct 21, 2024
BUY
$9.14 - $24.62 $330,794 - $891,047
36,192 Added 257.21%
50,263 $470,000
Q3 2023

Nov 07, 2023
BUY
$9.14 - $24.62 $330,794 - $891,047
36,192 Added 257.21%
50,263 $470,000
Q2 2023

Oct 21, 2024
SELL
$23.2 - $27.29 $2 Million - $2.36 Million
-86,382 Reduced 85.99%
14,071 $345,000
Q2 2023

Aug 07, 2023
SELL
$23.2 - $27.29 $2 Million - $2.36 Million
-86,382 Reduced 85.99%
14,071 $345,000
Q1 2023

Oct 21, 2024
SELL
$22.26 - $30.85 $339,019 - $469,845
-15,230 Reduced 13.17%
100,453 $2.34 Million
Q1 2023

May 03, 2023
BUY
$22.26 - $30.85 $1.34 Million - $1.86 Million
60,162 Added 149.32%
100,453 $2.34 Million
Q4 2022

Feb 13, 2023
BUY
$19.96 - $28.22 $468,880 - $662,916
23,491 Added 139.83%
40,291 $1.02 Million
Q3 2022

Nov 07, 2022
BUY
$18.26 - $31.1 $306,768 - $522,480
16,800 New
16,800 $324,000
Q2 2022

Aug 09, 2022
SELL
$19.08 - $26.7 $465,819 - $651,853
-24,414 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$21.19 - $40.01 $517,332 - $976,804
24,414 New
24,414 $628,000
Q3 2021

Nov 12, 2021
SELL
$34.9 - $54.54 $1.29 Million - $2.02 Million
-36,951 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$38.75 - $51.0 $13,523 - $17,799
-349 Reduced 0.94%
36,951 $1.75 Million
Q1 2021

May 17, 2021
BUY
$26.34 - $83.07 $219,965 - $693,717
8,351 Added 28.85%
37,300 $1.91 Million
Q4 2020

Feb 12, 2021
BUY
$25.51 - $43.38 $738,488 - $1.26 Million
28,949 New
28,949 $775,000

Others Institutions Holding VIR

# of Institutions
218
Shares Held
87M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $979M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email